Aborted Cardiac Arrest in LQT2 Related to Novel KCNH2 (hERG) Variant Identified in One Lithuanian Family

Medicina (Kaunas). 2021 Jul 16;57(7):721. doi: 10.3390/medicina57070721.

Abstract

Congenital long QT syndrome (LQTS) is a hereditary ion channelopathy associated with ventricular arrhythmia and sudden cardiac death starting from young age due to prolonged cardiac repolarization, which is represented by QT interval changes in electrocardiogram (ECG). Mutations in human ether-à-go-go related gene (KCNH2 (7q36.1), formerly named hERG) are responsible for Long QT syndrome type 2 (LQT2). LQT2 is the second most common type of LQTS. A resuscitated 31-year-old male with the diagnosis of LQT2 and his family are described. Sequencing analysis of their genomic DNA was performed. Amino acid alteration p.(Ser631Pro) in KCNH2 gene was found. This variant had not been previously described in literature, and it was found in three nuclear family members with different clinical course of the disease. Better understanding of genetic alterations and genotype-phenotype correlations aids in risk stratification and more effective management of these patients, especially when employing a trigger-specific approach to risk-assessment and individually tailored therapy.

Keywords: KCNH2; long QT syndrome type 2; mutation; sudden cardiac death.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Death, Sudden, Cardiac / etiology
  • ERG1 Potassium Channel / genetics
  • Ether-A-Go-Go Potassium Channels / genetics
  • Heart Arrest* / genetics
  • Humans
  • Long QT Syndrome* / complications
  • Long QT Syndrome* / genetics
  • Male
  • Mutation

Substances

  • ERG1 Potassium Channel
  • Ether-A-Go-Go Potassium Channels
  • KCNH2 protein, human